Company news: Physicians Interactive, Boehringer Ingelheim

Share this article:

Physicians Interactive named Dr. Gautam Gulati Chief Medical Officer and SVP of product management. Gulati will be overseeing product development lines. He was previously SVP at Digitas Health. Joe Caso was named EVP of new business. Caso's marketing focus will include marketing strategies that will retain prescription momentum for drugs that are aging out of their patent protection. Caso has worked with King Pharmaceuticals, Pfizer and Schering-Plough.

An anonymous physician complaint prompted the UK Prescription Medicines Code of Practice Authority to come down on German drug maker Boehringer Ingelheim, InPharm reported Thursday. The government agency found that BI's professional website for the blood thinner Pradaxa did not clearly indicate where users could find prescribing information. Instead, the site requires users to click the clinical indication, a location the doctor said was buried in promotional information. PMPCA agreed. 
Share this article:
close

Next Article in News

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZenca beefs up respiratory portfolio

AstraZenca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.